Eisai
"Eisai's human health care (hhc) mission is to give first thoughts to patients and their families by developing drugs for diseases with significant unmet medical need. This is particularly compelling in oncology, one of Eisai's long-standing therapeutic areas of focus since 1987.
As part of its hhc mission, Eisai continues to grow its commitment to oncology through research and clinical development, and in approved treatments for cancer and supportive care.
Among Eisai's areas of focus in oncology are: cutaneous T-cell lymphoma, AIDS-related Kaposi's sarcoma and advanced breast cancer."